Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature

Malaria remains the most serious infectious disease and is one of the leading causes of death among children in malaria endemic areas. The development of malaria vaccines has been underway since 1960s. Significant progress in the development of vaccine has been made in the last decade. On 6 October...

Full description

Bibliographic Details
Main Authors:	Abdullah Nadeem, Wajeeha Bilal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Asian Pacific Journal of Tropical Medicine
Subjects:	rts s/as01; malaria; plasmodium; vaccine
Online Access:	http://www.apjtm.org/article.asp?issn=1995-7645;year=2023;volume=16;issue=4;spage=162;epage=168;aulast=Nadeem

Similar Items

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
by: Hassan Mumtaz, et al.
Published: (2023-06-01)

RTS,S/AS01 vaccine (Mosquirix™): an overview
by: Matthew B. Laurens
Published: (2020-03-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
by: Arora N, et al.
Published: (2021-03-01)

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
by: Shima Mahmoudi, et al.
Published: (2017-09-01)

The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone
by: Matthew Cairns, et al.
Published: (2022-10-01)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
by: Philippe Moris, et al.
Published: (2018-01-01)

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up
by: Nicolas Praet, et al.
Published: (2022-04-01)

Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
by: Itziar Ubillos, et al.
Published: (2018-10-01)

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
by: Robert M. Mugo, et al.
Published: (2021-12-01)

RTS,S/AS01 malaria vaccine pilot implementation in western Kenya: a qualitative longitudinal study to understand immunisation barriers and optimise uptake
by: Jenna Hoyt, et al.
Published: (2023-11-01)

RTS,S/AS01E vaccine defaults in Ghana: a qualitative exploration of the perspectives of defaulters and frontline health service providers
by: Joshua Okyere, et al.
Published: (2023-09-01)

Le vaccin antipaludique RTS,S/AS01 chez les enfants âgés de 5 à 17 mois au moment de la première vaccination
by: Pascale Vandoolaeghe, et al.
Published: (2018-06-01)

Humoral Immune Responses to P. falciparum Circumsporozoite Protein (Pfcsp) Induced by the RTS, S Vaccine – Current Update
by: Ngulube P
Published: (2023-04-01)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
by: Yolanda Guerra Mendoza, et al.
Published: (2019-10-01)

RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study
by: Carlota Dobaño, et al.
Published: (2019-08-01)

The RTS,S malaria vaccine: Journey from conception to recommendation
by: Oluwaseyi Muyiwa Egbewande
Published: (2022-12-01)

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
by: Innocent Valéa, et al.
Published: (2018-06-01)

Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya
by: Angela K. Moturi, et al.
Published: (2023-09-01)

Modelling population-level impact to inform target product profiles for childhood malaria vaccines
by: Alexandra B. Hogan, et al.
Published: (2018-07-01)

Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01E malaria vaccine in three regions of Ghana: a qualitative study
by: Jane Grant, et al.
Published: (2022-05-01)

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial
by: Innocent Valéa, et al.
Published: (2020-06-01)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
by: Lorenz von Seidlein, et al.
Published: (2020-01-01)

Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
by: Elizabeth Adrianne Hammershaimb, et al.
Published: (2024-12-01)

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure
by: Liriye Kurtovic, et al.
Published: (2019-02-01)

Commentary in reply to a publication on Plasmodium falciparum pre-erythrocytic stage vaccine development
by: François P. Roman, et al.
Published: (2020-07-01)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
by: Corinne S. Merle, et al.
Published: (2023-08-01)

Adoption of RTS, S malaria vaccine for children younger than 5 years in Rwanda: A budget impact analysis
by: Cyrille Ndikumukiza, et al.
Published: (2021-09-01)

Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
by: Yihunie W, et al.
Published: (2023-03-01)

Assessing the Implementation Determinants of Pilot Malaria Vaccination Programs in Ghana, Kenya, and Malawi through a Complexity Lens: A Rapid Review Using a Consolidated Framework for Implementation Research
by: Abdu A. Adamu, et al.
Published: (2024-01-01)

Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
by: H. Juliette T. Unwin, et al.
Published: (2021-11-01)

Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
by: Nouh Saad Mohamed, et al.
Published: (2021-11-01)

A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
by: Arif Jamal Siddiqui, et al.
Published: (2023-04-01)

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study
by: Gemma Moncunill, et al.
Published: (2022-01-01)

Malaria therapeutics: are we close enough?
by: Himani Tripathi, et al.
Published: (2023-04-01)

Predictors of malaria vaccine uptake among children 6–24 months in the Kassena Nankana Municipality in the Upper East Region of Ghana
by: Dominic Yeboah, et al.
Published: (2022-11-01)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
by: Aroosa Younis Nadeem, et al.
Published: (2022-04-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
by: Griffin J. Bell, et al.
Published: (2020-06-01)

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02<sub>D</sub> malaria vaccine in infants living in a malaria-endemic region
by: Abdulla Salim, et al.
Published: (2013-01-01)

Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021
by: Michael Rockson Adjei, et al.
Published: (2023-03-01)

Factors associated with malaria vaccine uptake in Nsanje district, Malawi
by: Atusaye J. Simbeye, et al.
Published: (2024-04-01)